SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-19-016384
Filing Date
2019-11-04
Accepted
2019-11-04 16:15:16
Documents
2
Period of Report
2019-11-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1558
2 ex24-1.htm EX-24.1 14785
  Complete submission text file 0001493152-19-016384.txt   17989
Mailing Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD SUITE 350 DURHAM NC 27703 919-578-5901
Adhera Therapeutics, Inc. (Issuer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 5001 SOUTH MIAMA BOULEVARD SUITE 300 DURHAM NC 27703
Business Address
Stanley Rhonda L. (Reporting) CIK: 0001566045 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-13789 | Film No.: 191189971